Primary Device ID | B141QANGIOXA730 |
NIH Device Record Key | 35971f89-3f4e-466f-abfb-2cfec8e9b3f9 |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | QAngio XA |
Version Model Number | 7.3 |
Company DUNS | 549961191 |
Company Name | Medis Medical Imaging Systems B.V. |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | false |
Lot Batch | false |
Serial Number | true |
Manufacturing Date | true |
Expiration Date | false |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl | |
Phone | +31715241700 |
support@medis.nl |
Device Issuing Agency | Device ID |
---|---|
HIBCC | B141QANGIOXA730 [Primary] |
LLZ | System, Image Processing, Radiological |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 3 |
Public Version Date | 2018-07-06 |
Device Publish Date | 2016-06-13 |
B141MEDISSUITEMRCT20230 - Medis Suite MRCT | 2023-06-13 Medis Suite MRCT 2023 is indicated for use in clinical settings where more reproducible than manually derived quantified results |
B141MEDISSUITEXA20230 - Medis Suite XA | 2023-06-13 Medis Suite XA 2023 is indicated for use in clinical settings where validated and reproducible quantified results are needed to |
B141MEDISSUITEMRCT20220 - Medis Suite MRCT | 2022-05-24 Medis Suite MRCT 2022 is indicated for use in clinical settings where more reproducible than manually derived quantified results |
B141MEDISSUITEXA20220 - Medis Suite XA | 2022-05-24 Medis Suite XA 2022 is indicated for use in clinical settings where validated and reproducible quantified results are needed to |
B141MEDISSUITEMRCT20210 - Medis Suite MRCT | 2021-10-19 Medis Suite MRCT 2021 is indicated for use in clinical settings where more reproducible than manually derived quantified results |
B141MEDISSUITEXA20210 - Medis Suite XA | 2021-10-19 Medis Suite XA is indicated for use in clinical settings where validated and reproducible quantified results are needed to suppo |
B141MEDISSUITEMRCT20200 - Medis Suite MRCT | 2020-09-21 Medis Suite MRCT is indicated for use in clinical settings where more reproducible than manually derived quantified results are |
B141MEDISSUITEXA20200 - Medis Suite XA | 2020-09-21 Medis Suite XA is indicated for use in clinical settings where validated and reproducible quantified results are needed to suppo |